Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
出版年份 2015 全文链接
标题
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
作者
关键词
-
出版物
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 90, Issue 1, Pages 61-72
出版商
Wiley
发表日期
2015-06-23
DOI
10.1002/cyto.b.21265
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New criteria for response assessment: role of minimal residual disease in multiple myeloma
- (2015) B. Paiva et al. BLOOD
- The development of potential antibody-based therapies for myeloma
- (2015) Daniel W. Sherbenou et al. BLOOD REVIEWS
- Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of “normal” residual plasma cell analysis
- (2015) Fanny Pojero et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium
- (2014) Ola Landgren et al. AMERICAN JOURNAL OF HEMATOLOGY
- SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
- (2014) J. Deckert et al. CLINICAL CANCER RESEARCH
- Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy
- (2014) Stéphanie Mathis et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
- (2014) B. Paiva et al. HAEMATOLOGICA
- Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome
- (2014) Murielle Roussel et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunophenotype of Normal and Myelomatous Plasma-Cell Subsets
- (2014) Nelly Robillard et al. Frontiers in Immunology
- Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity
- (2013) A. Flanders et al. BLOOD
- CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
- (2013) André Veillette et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- CD38 and CD157: A long journey from activation markers to multifunctional molecules
- (2013) Valeria Quarona et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
- (2013) N Puig et al. LEUKEMIA
- New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
- (2013) E M Ocio et al. LEUKEMIA
- Overview of clinical flow cytometry data analysis: recent advances and future challenges
- (2013) Carlos E. Pedreira et al. TRENDS IN BIOTECHNOLOGY
- A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma
- (2013) N Robillard et al. Blood Cancer Journal
- Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
- (2012) Roger G. Owen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- (2012) Sagar Lonial et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma
- (2012) Dingsheng Liu et al. JOURNAL OF CLINICAL PATHOLOGY
- Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
- (2012) B Paiva et al. LEUKEMIA
- EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
- (2012) T Kalina et al. LEUKEMIA
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- FcRL5 as a Target of Antibody-Drug Conjugates for the Treatment of Multiple Myeloma
- (2012) K. Elkins et al. MOLECULAR CANCER THERAPEUTICS
- Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
- (2011) Daisy Alapat et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma
- (2011) J. A. Zonder et al. BLOOD
- Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma
- (2011) D. Atanackovic et al. HAEMATOLOGICA
- Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
- (2011) Bruno Paiva et al. JOURNAL OF CLINICAL ONCOLOGY
- Human peripheral blood B-cell compartments: A crossroad in B-cell traffic
- (2010) M. Perez-Andres et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells
- (2010) A. Caraux et al. HAEMATOLOGICA
- Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping
- (2010) E S Costa et al. LEUKEMIA
- Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
- (2009) Ritu Gupta et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells
- (2009) Y.-T. Tai et al. BLOOD
- Constitutively lower expressions of CD54 on primary myeloma cells and their different localizations in bone marrow
- (2009) Mohd S. Iqbal et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease
- (2009) E. Domingo et al. HAEMATOLOGICA
- Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients
- (2008) S. Quijano et al. BLOOD
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach
- (2008) Bridget E. McLaughlin et al. CYTOMETRY PART A
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
- (2008) Gema Mateo et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
- (2008) K Hatano et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started